x

Posted 05 January, 2024

SomaLogic, Inc. appointed Dr. Egholm as new CEO

Nasdaq:SLGC appointed new Chief Executive Officer Dr. Egholm in a 8-K filed on 05 January, 2024.


  Dr. Egholm, the President, Chief Executive Officer, Treasurer and Secretary of Merger Sub, was appointed to the officer positions of President, Chief Executive Officer, Treasurer and Secretary of SomaLogic, which are the only officer positions of SomaLogic immediately following the effective time of the Merger.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of SomaLogic, Inc.
None • None
SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company was founded by Larry Gold in 2000 and is headquartered in Boulder, CO.
Market Cap
N/A
View Company Details
SomaLogic, Inc. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


Directors


In connection with the closing of the Merger and pursuant to the terms of the Merger Agreement, all of the members of SomaLogic's board of directors (the "SomaLogic Board") resigned as of the effective time of the Merger. As previously disclosed, Tom Carey, Troy Cox and Kathy Hibbs will serve on Standard BioTools' board of directors. No director resigned as a result of any disagreement with SomaLogic on any matter relating to SomaLogic's operations, policies or practices.


Effective immediately following the resignations described above, Michael Egholm, Ph.D., Jeffrey Black, and Hanjoon Alex Kim were appointed as the directors of the SomaLogic Board.


Officers


In addition, as of the closing of the Merger, the executive officers of SomaLogic ceased to be executive officers of SomaLogic. No officers resigned as a result of any disagreement with SomaLogic on any matter relating to SomaLogic's operations, policies or practices. Dr. Egholm, the President, Chief Executive Officer, Treasurer and Secretary of Merger Sub, was appointed to the officer positions of President, Chief Executive Officer, Treasurer and Secretary of SomaLogic, which are the only officer positions of SomaLogic immediately following the effective time of the Merger.


The information set forth in Item 2.01 of this Current Report on Form 8-K regarding the conversion of SomaLogic equity awards is incorporated by reference into this Item 5.02.